Impact of lysine-affinity chromatography on supercoiled plasmid DNA purification

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 30, 2011, Pages 3507-3515

  Sousa, A ^a   Sousa, F ^a   Queiroz, J A ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Lysine affinity chromatography; Non viral vectors; Supercoiled plasmid DNA; Transfection efficiency

Indexed keywords

BIOLOGICAL AGENTS; CELL UPTAKE; DNA VACCINATION; ENABLING TECHNOLOGIES; EUKARYOTIC CELLS; GENE TRANSFECTION; IMPURITIES IN; ISOFORMS; LYSINE-AFFINITY CHROMATOGRAPHY; NEW STRATEGY; NONVIRAL; NONVIRAL VECTORS; PLASMID DNA; QUALITY CONTROL TESTS; SUPERCOILED; THERAPEUTIC APPLICATION; THERAPY DELIVERY; TRANSFECTION EFFICIENCY;

AFFINITY CHROMATOGRAPHY; AMINO ACIDS; BIOMOLECULES; DISEASE CONTROL; DISEASES; EFFICIENCY; ESCHERICHIA COLI; GENE THERAPY; GENETIC ENGINEERING; PURIFICATION;

DNA;

ENDOTOXIN; FLUORESCEIN ISOTHIOCYANATE; LIPOFECTAMINE; LYSINE; PLASMID DNA;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; DNA PURIFICATION; DNA SUPERCOILING; ESCHERICHIA COLI; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ISOLATION PROCEDURE; LYSINE AFFINITY CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, AFFINITY; COS CELLS; DNA, SUPERHELICAL; ESCHERICHIA COLI; GENETIC VECTORS; HELA CELLS; HUMANS; LYSINE; MICROSCOPY, CONFOCAL; PLASMIDS; TRANSFECTION;

ESCHERICHIA COLI; EUKARYOTA;

EID: 80555149385     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.09.032     Document Type: Article

References (41)

1. Schleef M., Schmidt T. J. Gene Med. 2004, 6:S45.
2. Brave A., Ljungberg K., Wahren B., Liu M.A. Mol. Pharm. 2007, 4:18.
3. Anderson R.J., Schneider J. Vaccine 2007, 25:B24.
4. Sebestyen M.G., Hegge J.O., Noble M.A., Lewis D.L., Herweijer H., Wolff J.A. Hum. Gene Ther. 2007, 18:269.
5. Gill D.R., Pringle I.A., Hyde S.C. Gene Ther. 2009, 16:165.
6. Seow Y., Wood M.J. Mol. Ther. 2009, 17:767.
7. Luo D., Saltzman W.M. Nat. Biotechnol. 2000, 18:33.
8. Mountain A. Trends Biotechnol. 2000, 18:119.
9. Smrekar F., Podgornik A., Ciringer M., Kontrec S., Raspor P., Strancar A., Peterka M. Vaccine 2010, 28:2039.
10. Stadler J., Lemmens R., Nyhammar T. J. Gene Med. 2004, 6:S54.
11. Ferreira G.N., Monteiro G.A., Prazeres D.M.F., Cabral J.M. Trends Biotechnol. 2000, 18:380.
12. Ferreira G.N., Cabral J.M., Prazeres D.M.F. Biotechnol. Prog. 1999, 15:725.
13. Sousa F., Prazeres D.M.F., Queiroz J.A. Trends Biotechnol. 2008, 26(9):518.
14. Diogo M.M., Queiroz J.A., Prazeres D.M.F. J. Chromatogr. A 2005, 1069:3.
15. Sousa A., Bicho D., Tomaz C.T., Sousa F., Queiroz J.A. J. Chromatogr. A 2011, 1218:1701.
16. Cupillard L., Juillard V., Latour S., Colombet G., Cachet N., Richard S., Blanchard S., Fischer L. Vaccine 2005, 23:1910.
17. Cherng J.Y., Schuurmans-Nieuwenbroek N.M., Jiskoot W., Talsma H., Zuidam N.J., Hennink W.E., Crommelin D.J. J. Control. Release 1999, 60:343.
18. Lowe C.R., Lowe A.R., Gupta G. J. Biochem. Biophys. Methods 2001, 49:561.
19. Sousa F., Cruz C., Queiroz J.A. J. Mol. Recogn. 2010, 23:505.
20. Luscombe N.M., Laskowski R.A., Thornton J.M. Nucleic Acids Res. 2001, 29:2860.
21. Hoffman M.M., Khrapov M.A., Cox J.C., Yao J., Tong L., Ellington A.D. Nucleic Acids Res. 2004, 32:D174.
22. Sousa F., Tomaz C.T., Prazeres D.M.F., Queiroz J.A. Anal. Biochem. 2005, 343:183.
23. Sousa F., Freitas S., Azzoni A.R., Prazeres D.M.F., Queiroz J.A. Biotechnol. Appl. Biochem. 2006, 45:131.
24. Sousa F., Matos T., Prazeres D.M.F., Queiroz J.A. Anal. Biochem. 2008, 374:432.
25. Sousa F., Prazeres D.M.F., Queiroz J.A. J. Gene Med. 2008, 11:79.
26. Sousa A., Sousa F., Queiroz J.A. J. Chromatogr. B 2009, 877:3257.
27. Sousa A., Sousa F., Queiroz J.A. J. Sep. Sci. 2010, 33:2610.
28. Sambrook J., Fritisch E., Maniatis T. Molecular cloning: A laboratory Manual 1989, Cold Spring Harbor Laboratory Press, New York.
29. Diogo M.M., Queiroz J.A., Monteiro G.A., Martins S.A., Ferreira G.N., Prazeres D.M.F. Biotechnol. Bioeng. 2000, 68:576.
30. Diogo M.M., Queiroz J.A., Prazeres D.M.F. J. Chromatogr. A 2003, 998:109.
31. Martins S.A., Prazeres D.M.F., Cabral J.M., Monteiro G.A. Anal. Biochem. 2003, 322:127.
32. Ishii T., Okahata Y., Sato T. Chem. Lett. 2000, 386.
33. Mondal K., Gupta M.N. Biomol. Eng. 2006, 23:59.
34. Wils P., Escriou V., Warnery A., Lacroix F., Lagneaux D., Ollivier M., Crouzet J., Mayaux J.F., Scherman D. Gene Ther. 1997, 4:323.
35. Ishii T., Okahata Y., Sato T. Biochim. Biophys. Acta 2001, 1514:51.
36. Erbacher P., Zou S., Bettinger T., Steffan A.M., Remy J.S. Pharm. Res. 1998, 15:1332.
37. Strick T.R., Allemand J.F., Bensimon D., Croquette V. Biophys. J. 1998, 74:2016.
38. Sousa F., Prazeres D.M.F., Queiroz J.A. Arch Biochem. Biophys. 2007, 467:154.
39. Diogo M.M., Ribeiro S.C., Queiroz J.A., Monteiro G.A., Tordo N., Perrin P., Prazeres D.M.F. J. Gene Med. 2001, 3:577.
40. Wooddell C.I., Subbotin V.M., Sebestyen M.G., Griffin J.B., Zhang G., Schleef M., Braun S., Huss T., Wolff J.A. Hum. Gene Ther. 2011, 22:225.
41. Gaspar V.M., Correia I.J., Sousa A., Silva F., Paquete C.M., Queiroz J.A., Sousa F. J. Control. Release 2011, 10.1016/j.jconrel.2011.08.007.